arginine and refludan

arginine has been researched along with refludan in 101 studies

Research

Studies (101)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	2 (1.98)	18.2507
2000's	74 (73.27)	29.6817
2010's	25 (24.75)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Prasa, D; Stürzebecher, J; Svendsen, L	1
Jang, IK; Januzzi, JL	1
Greinacher, A; Lubenow, N	2
Baglin, TP	1
Creekmore, F	1
Dager, WE; White, RH	1
Wittkowsky, AK	1
Mendez, MN; Tong, LM	1
Warkentin, TE	4
Smythe, MA; Warkentin, TE	1
Jeske, WP; Walenga, JM	1
Mattson, JC; Smythe, MA; Stephens, JL; Warkentin, TE; Zakalik, D	1
Fenyvesi, T; Harenberg, J; Jörg, I	1
Fenyvesi, T; Harenberg, J; Joerg, I	1
Nguyen, PH; Rice, L; Vann, AR	1
Mukundan, S; Zeigler, ZR	1
Greinacher, A	1
Cleveland, KW	1
Heddle, N; Hirsh, J; Kelton, JG	1
Dager, WE; Gosselin, RC; Janatpour, K; King, JH; Larkin, EC; Mahackian, K; Owings, JT	1
Dager, WE; Gosselin, RC; Janatpour, KA; King, JH; Larkin, EC; Owings, JT	1
Call, JT; Deliargyris, EN; Sane, DC	1
Dangas, GD; Nikolsky, E	1
Dager, WH; Gosselin, RC; Janatpur, KA; King, JH; Larkin, EC; Owings, JT	1
White, CM	1
Bartholomew, JR	1
Woodyard, DN	1
Almahameed, A; Bartholomew, JR; Begelman, SM	1
Fenyvesi, T; Harenberg, J; Ingrid, J; Job, H; Jörg, I; Lukas, P; Piazolo, L; Tivadar, F	1
Gray, E; Harenberg, J	1
Abrams, CS; Pollak, ES	1
Smith, KM; Taylor, LM	1
McIntosh, BA	1
Hyers, TM	1
Hallisey, RK; John, TE	1
Bick, RL; Fareed, J; Messmore, HL; Walenga, JM	1
Koerber, JM; Mattson, JC; Smythe, MA; Stephens, JL	1
Fish, DN; Jung, R; Kiser, TH; MacLaren, R	1
Craven, S; Dewar, L; Greinacher, A; Ofosu, FA; Sheppard, JA; Warkentin, TE	1
Matthai, WH	1
Baker, KM; Flattery, MP	1
Dang, CH; Durkalski, VL; Nappi, JM	1
Gurley, WQ; Kirklin, JK; Lell, WA; Nielsen, VG; Pereira, SJ; Steenwyk, BL	1
Boshkov, LK; Kirby, A; Shen, I; Ungerleider, RM	1
Almahameed, A; Napolitano, LM; Nasraway, SA; Warkentin, TE	1
Cooney, MF	1
Hursting, MJ; Lewis, BE	1
Fraser, JF; O'Connor, ED	1
Haas, S; Höhnke, C	1
Marymont, JH; Murphy, GS	1
Greinacher, A; Selleng, K; Warkentin, TE	1
Dager, WE; Dougherty, JA; Militello, MA; Nguyen, PH; Smythe, MA	1
Baroletti, S; Fanikos, J; Fiumara, K; Goldhaber, SZ; Luppi, C; Mehta, A; Saniuk, C; Silverman, J	1
Fischer, KG	1
Bong, M; Di Cesare, PE; Patel, VP	1
Ahmed, I; Majeed, A; Powell, R	1
Cappellini, MD; Cassinerio, E; Castelli, R; Fabris, F; Graziadei, G; Porro, F	1
Agnelli, G; Filippucci, E; Iorio, A; Vedovati, MC	1
Lepor, NE	1
Chiappe, J; Fugate, S	1
Prechel, M; Walenga, JM	1
Ansell, JE; Dinwoodey, DL	1
Chevalier, A; Nutescu, EA; Shapiro, NL	1
Rolfes, C; Steinfeldt, T	1
Colemen, CI; Talati, R; White, CM	1
Greinacher, A; Haneya, A; Hirt, S; Schmid, C; Selleng, K; Selleng, S	1
Billett, HH; Cheng-Lai, A; Curzio, KM; Kheyfets, V; Sinnet, M	1
Kalb, ML; Kozek-Langenecker, SA; Potura, L; Scharbert, G	1
Chong, BH; Isaacs, A	1
Christoffersen, C; Gøtze, JP; Lethagen, S	1
Chong, BH; Lip, GYH; Shantsila, E	1
Levy, JH; Winkler, AM	1
Ortel, TL	1
Bark, N; Blombäck, M; He, S; Johnsson, H; Wallén, NH	1
Ivandic, B; Zorn, M	1
Oo, TH	1
Fries, D	1
Antovic, JP; Armstrong, E; Baghaei, F; Dalsgaard-Nielsen, J; Hillarp, A; Holme, PA; Holmström, M; Johnsson, H; Joutsi-Korhonen, L; Lassila, R; Sandset, PM	1
Kennedy, K; King, S; Poe, K; Reeves, J; Short, M; Steinke, D	1
Corbets, LR; Forsyth, LL; Koerber, JM; Mehta, TP; Melendy, SM; Parikh, R; Smythe, MA; Sykes, E	1
Aguilera, TA; Baik, FM; Baird, SM; Crisp, JL; Friedman, B; Jiang, T; Nguyen, QT; Olson, ES; Tsien, RY; Tsimikas, S; Whitney, MA	1
Knovich, MA; Lesser, GJ; Strowd, RE	1
Abel, EE; Kane-Gill, SL; Kellum, JA; Seybert, AL	1
Cruz-González, I; López-Jiménez, R; Perez-Rivera, A; Yan, BP	1
Coppens, M; Eikelboom, JW; Gustafsson, D; Hirsh, J; Weitz, JI	1
Curvers, J; Scharnhorst, V; Stroobants, AK; van de Kerkhof, D; van den Dool, EJ	1
Fritsma, GA	1
Bereczky, Z; Boda, Z; Kappelmayer, J; Kerenyi, A; Olah, Z; Szarvas, M	1
Moffett, BS; Teruya, J	1
Bahlmann, A; Beiderlinden, M; Brezina, T; Geib, J; Golla, E; Greinacher, A; Kienbaum, P; Kindgen-Milles, D; Pannen, B; Schaefer, MS; Treschan, TA; Werner, P	1
Bain, J; Meyer, A	1
Harada, MY; Hoang, DM; Ley, EJ; Margulies, DR; Mason, R; Murry, JS; Nuño, M; Sun, BJ; Volod, O; Zaw, AA	1
Kolde, HJ; Seidel, H	1
Lan, X; Li, S; Sun, Z; Tang, Z; Xi, Y; Zhao, H	1
Banik, N; Beyer-Westendorf, J; Brachmann, J; Dohmen, PM; Eberle, S; Hankowitz, J; Klamroth, R; Kropff, S; Lindhoff-Last, E; Madlener, K; Müller, MM; Pötzsch, B; Schellong, S; Schindewolf, M; Steindl, J	1
Ananth, CV; D'Alton, ME; Eisenberger, AB; Friedman, AM; Sagaram, D; Siddiq, Z; Wright, JD	1
Bahlmann, A; Beiderlinden, M; Brezina, T; Görlinger, K; Kemper, J; Kienbaum, P; Schäfer, M; Seidel, H; Treschan, TA; Werner, P	1

Reviews

48 review(s) available for arginine and refludan

Article	Year
Heparin induced thrombocytopenia: diagnosis and contemporary antithrombin management. Journal of thrombosis and thrombolysis, 1999, Volume: 7, Issue:3 Topics: Ancrod; Arginine; Chondroitin Sulfates; Dermatan Sulfate; Drug Combinations; Fibrinolytic Agents; Forecasting; Gangrene; Hemorrhage; Heparin; Heparitin Sulfate; Hirudin Therapy; Hirudins; Humans; Pipecolic Acids; Platelet Aggregation; Protein C; Recombinant Proteins; Sulfonamides; Thrombin; Thrombocytopenia; Warfarin	1999
Management of patients with heparin-induced thrombocytopenia: focus on recombinant hirudin. Journal of thrombosis and thrombolysis, 2000, Volume: 10 Suppl 1 Topics: Anticoagulants; Antithrombins; Arginine; Chondroitin Sulfates; Clinical Trials as Topic; Critical Pathways; Dermatan Sulfate; Drug Combinations; Fibrinolytic Agents; Heparin; Heparinoids; Heparitin Sulfate; Hirudin Therapy; Hirudins; Humans; Pipecolic Acids; Recombinant Proteins; Sulfonamides; Thrombocytopenia	2000
Heparin induced thrombocytopenia thrombosis (HIT/T) syndrome: diagnosis and treatment. Journal of clinical pathology, 2001, Volume: 54, Issue:4 Topics: Anticoagulants; Arginine; Heparin; Hirudin Therapy; Hirudins; Humans; Pipecolic Acids; Platelet Count; Recombinant Proteins; Sulfonamides; Thrombocytopenia; Thrombosis	2001
Treatment of heparin-induced thrombocytopenia. The Annals of pharmacotherapy, 2002, Volume: 36, Issue:3 Topics: Animals; Anticoagulants; Arginine; Chondroitin Sulfates; Clinical Trials as Topic; Coronary Disease; Dermatan Sulfate; Drug Combinations; Female; Heparin; Heparitin Sulfate; Hirudin Therapy; Hirudins; Humans; Pipecolic Acids; Pregnancy; Rabbits; Recombinant Proteins; Sulfonamides; Thrombocytopenia	2002
The role of thrombin inhibition during percutaneous coronary intervention. Pharmacotherapy, 2002, Volume: 22, Issue:6 Pt 2 Topics: Angioplasty, Balloon, Coronary; Arginine; Clinical Trials as Topic; Coronary Disease; Coronary Thrombosis; Fibrinolytic Agents; Fondaparinux; Heparin; Hirudins; Humans; Peptide Fragments; Pipecolic Acids; Polysaccharides; Recombinant Proteins; Sulfonamides; Thrombin	2002
Therapeutic considerations in the management of patients with heparin-induced thrombocytopenia. Progress in cardiovascular nursing, 2002,Summer, Volume: 17, Issue:3 Topics: Anticoagulants; Arginine; Azetidines; Benzylamines; Fondaparinux; Heparin; Hirudin Therapy; Hirudins; Humans; Pipecolic Acids; Polysaccharides; Prodrugs; Recombinant Proteins; Sulfonamides; Thrombin; Thrombocytopenia	2002
Current agents for the treatment of patients with heparin-induced thrombocytopenia. Current opinion in pulmonary medicine, 2002, Volume: 8, Issue:5 Topics: Anticoagulants; Antithrombins; Arginine; Autoimmune Diseases; Chondroitin Sulfates; Dermatan Sulfate; Drug Combinations; Heparin; Heparitin Sulfate; Hirudin Therapy; Hirudins; Humans; Pipecolic Acids; Recombinant Proteins; Sulfonamides; Thrombocytopenia; Warfarin	2002
Antithrombotic drugs for the treatment of heparin-induced thrombocytopenia. Current opinion in investigational drugs (London, England : 2000), 2002, Volume: 3, Issue:8 Topics: Animals; Anticoagulants; Antithrombins; Arginine; Chondroitin Sulfates; Dermatan Sulfate; Drug Combinations; Fibrinolytic Agents; Heparin; Heparin, Low-Molecular-Weight; Heparitin Sulfate; Hirudins; Humans; Pipecolic Acids; Platelet Aggregation Inhibitors; Recombinant Proteins; Sulfonamides; Thrombocytopenia	2002
Hirudin in heparin-induced thrombocytopenia. Seminars in thrombosis and hemostasis, 2002, Volume: 28, Issue:5 Topics: Anticoagulants; Antithrombins; Arginine; Blood Coagulation; Chondroitin Sulfates; Clinical Trials as Topic; Dermatan Sulfate; Drug Combinations; Fibrinolytic Agents; Heparin; Heparitin Sulfate; Hirudin Therapy; Hirudins; Humans; Pipecolic Acids; Recombinant Proteins; Sulfonamides; Thrombocytopenia; Thrombosis; Time Factors	2002
Management of heparin-induced thrombocytopenia: a critical comparison of lepirudin and argatroban. Thrombosis research, 2003, May-01, Volume: 110, Issue:2-3 Topics: Anticoagulants; Antithrombins; Arginine; Female; Heparin; Hirudins; Humans; Middle Aged; Pipecolic Acids; Recombinant Proteins; Sulfonamides; Thrombocytopenia	2003
Argatroban, a new treatment option for heparin-induced thrombocytopenia. Critical care nurse, 2003, Volume: 23, Issue:6 Topics: Anticoagulants; Antithrombins; Arginine; Blood Coagulation; Blood Coagulation Tests; Chondroitin Sulfates; Critical Care; Dermatan Sulfate; Drug Combinations; Drug Costs; Drug Monitoring; Heparin; Heparitin Sulfate; Hirudins; Humans; Pipecolic Acids; Recombinant Proteins; Sulfonamides; Thrombocytopenia	2003
Treatment of heparin-induced thrombocytopenia: a critical review. Archives of internal medicine, 2004, Feb-23, Volume: 164, Issue:4 Topics: Anticoagulants; Arginine; Heparin; Hirudins; Humans; Pipecolic Acids; Recombinant Proteins; Risk Assessment; Sulfonamides; Thrombocytopenia; Thrombosis	2004
Direct thrombin inhibitors in the treatment of immune-mediated heparin-induced thrombocytopenia. Seminars in thrombosis and hemostasis, 2004, Volume: 30, Issue:3 Topics: Anticoagulants; Arginine; Binding Sites; Heparin; Hirudins; Humans; Models, Biological; Pipecolic Acids; Recombinant Proteins; Sulfonamides; Syndrome; Thrombin; Thrombocytopenia; Treatment Outcome	2004
Percutaneous interventions in patients with immune-mediated heparin-induced thrombocytopenia. Seminars in thrombosis and hemostasis, 2004, Volume: 30, Issue:3 Topics: Anticoagulants; Arginine; Blood Platelets; Heparin; Hirudins; Humans; Peptide Fragments; Pipecolic Acids; Recombinant Proteins; Skin; Sulfonamides; Thrombin; Thrombocytopenia; Time Factors	2004
Heparin-induced thrombocytopenia: diagnosis and management. Circulation, 2004, Nov-02, Volume: 110, Issue:18 Topics: Anticoagulants; Aortic Valve Insufficiency; Arginine; Autoantibodies; Autoimmune Diseases; Female; Fingers; Heart Valve Prosthesis Implantation; Heparin; Hirudins; Humans; Ischemia; Middle Aged; Necrosis; Pipecolic Acids; Platelet Activation; Platelet Factor 4; Postoperative Complications; Raynaud Disease; Recombinant Proteins; Sulfonamides; Thrombocytopenia; Thrombosis; Toes; Warfarin	2004
Thrombin-directed inhibitors: pharmacology and clinical use. American heart journal, 2005, Volume: 149, Issue:1 Suppl Topics: Anticoagulants; Arginine; Azetidines; Benzylamines; Blood Coagulation; Fondaparinux; Heparin; Hirudins; Humans; Peptide Fragments; Pipecolic Acids; Polysaccharides; Recombinant Proteins; Sulfonamides; Thrombin; Thrombosis; Warfarin	2005
Transition to an oral anticoagulant in patients with heparin-induced thrombocytopenia. Chest, 2005, Volume: 127, Issue:2 Suppl Topics: Administration, Oral; Anticoagulants; Arginine; Blood Coagulation; Blood Coagulation Factors; Chondroitin Sulfates; Dermatan Sulfate; Drug Combinations; Gangrene; Heparin; Heparitin Sulfate; Hirudins; Humans; Ischemia; Leg; Necrosis; Pipecolic Acids; Recombinant Proteins; Skin; Sulfonamides; Thrombocytopenia; Thrombosis; Warfarin	2005
An anesthesia provider's perspective of heparin-induced thrombocytopenia. AANA journal, 2005, Volume: 73, Issue:2 Topics: Anesthesia, General; Anticoagulants; Arginine; Drug Monitoring; Enzyme-Linked Immunosorbent Assay; Heparin; Hirudins; Humans; Intraoperative Care; Nurse Anesthetists; Pipecolic Acids; Platelet Count; Recombinant Proteins; Risk Factors; Sensitivity and Specificity; Severity of Illness Index; Sulfonamides; Thrombocytopenia; Thrombosis; Time Factors	2005
Heparin-induced thrombocytopenia: principles for early recognition and management. Cleveland Clinic journal of medicine, 2005, Volume: 72 Suppl 1 Topics: Anticoagulants; Arginine; Heparin; Heparin, Low-Molecular-Weight; Hirudins; Humans; Pipecolic Acids; Platelet Count; Practice Guidelines as Topic; Recombinant Proteins; Risk Assessment; Sulfonamides; Thrombocytopenia; Time Factors	2005
Clinical presentation and laboratory diagnosis of heparin-induced thrombocytopenia. Seminars in thoracic and cardiovascular surgery, 2005,Spring, Volume: 17, Issue:1 Topics: Anticoagulants; Arginine; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Heparin, Low-Molecular-Weight; Hirudins; Humans; Male; Pipecolic Acids; Recombinant Proteins; Risk Assessment; Severity of Illness Index; Sulfonamides; Thrombocytopenia; Thrombosis; Treatment Outcome	2005
Developing an algorithm for treating heparin-induced thrombocytopenia. Clinical advances in hematology & oncology : H&O, 2004, Volume: 2, Issue:4 Topics: Algorithms; Anticoagulants; Antigen-Antibody Complex; Arginine; Clinical Trials as Topic; Diagnosis, Differential; Disease Management; Follow-Up Studies; Hemorrhage; Heparin; Heparin, Low-Molecular-Weight; Hirudins; Humans; Immunoglobulin G; Pipecolic Acids; Platelet Activation; Platelet Count; Platelet Factor 4; Prognosis; Purpura, Thrombocytopenic, Idiopathic; Recombinant Proteins; Sulfonamides; Thrombocytopenia; Thrombophilia; Time Factors	2004
Heparin and other rapidly acting anticoagulants. Seminars in vascular surgery, 2005, Volume: 18, Issue:3 Topics: Anticoagulants; Arginine; Azetidines; Benzylamines; Embolism; Enzyme Inhibitors; Fondaparinux; Heparin; Heparin, Low-Molecular-Weight; Hirudins; Humans; Peptide Fragments; Pipecolic Acids; Polysaccharides; Recombinant Proteins; Sulfonamides; Thrombin; Thrombocytopenia; Venous Thrombosis	2005
Treatment of heparin-induced thrombocytopenia in cardiovascular patients. Expert opinion on pharmacotherapy, 2006, Volume: 7, Issue:3 Topics: Angioplasty, Balloon, Coronary; Anticoagulants; Arginine; Cardiovascular Diseases; Chondroitin Sulfates; Dermatan Sulfate; Drug Administration Schedule; Factor Xa Inhibitors; Fondaparinux; Heparin; Heparitin Sulfate; Hirudins; Humans; Pipecolic Acids; Polysaccharides; Postoperative Complications; Practice Guidelines as Topic; Randomized Controlled Trials as Topic; Recombinant Proteins; Sulfonamides; Thrombin; Thrombocytopenia	2006
Recognition and management of heparin-induced thrombocytopenia in pediatric cardiopulmonary bypass patients. The Annals of thoracic surgery, 2006, Volume: 81, Issue:6 Topics: Adolescent; Anticoagulants; Arginine; Autoantibodies; Cardiopulmonary Bypass; Child; Child, Preschool; Clinical Trials as Topic; Fatal Outcome; Female; Heart Defects, Congenital; Heparin; Hirudins; Hospitals, University; Humans; Hypoplastic Left Heart Syndrome; Infant; Infant, Newborn; Male; Multicenter Studies as Topic; Pipecolic Acids; Platelet Factor 4; Postoperative Complications; Postoperative Hemorrhage; Recombinant Proteins; Retrospective Studies; Sulfonamides; Thrombocytopenia; Thromboembolism; Treatment Outcome	2006
Heparin-induced thrombocytopenia in the critical care setting: diagnosis and management. Critical care medicine, 2006, Volume: 34, Issue:12 Topics: Anticoagulants; Arginine; Chondroitin Sulfates; Clinical Trials as Topic; Critical Care; Dermatan Sulfate; Heparin; Heparinoids; Heparitin Sulfate; Hirudins; Humans; Pipecolic Acids; Platelet Count; Recombinant Proteins; Risk Factors; Sulfonamides; Thrombin; Thrombocytopenia	2006
Heparin-induced thrombocytopenia: advances in diagnosis and treatment. Critical care nurse, 2006, Volume: 26, Issue:6 Topics: Administration, Oral; Anticoagulants; Arginine; Critical Care; Drug Monitoring; Enzyme-Linked Immunosorbent Assay; Heparin; Hirudins; Humans; International Normalized Ratio; Nurse's Role; Nursing Assessment; Partial Thromboplastin Time; Patient Selection; Pipecolic Acids; Platelet Count; Practice Guidelines as Topic; Recombinant Proteins; Risk Factors; Sulfonamides; Syndrome; Thrombocytopenia; Time Factors	2006
Direct thrombin inhibition during percutaneous coronary intervention in patients with heparin-induced thrombocytopenia. Expert review of cardiovascular therapy, 2007, Volume: 5, Issue:1 Topics: Angioplasty, Balloon, Coronary; Antithrombins; Arginine; Drug Interactions; Economics, Pharmaceutical; Fibrinolytic Agents; Hemorrhage; Heparin; Hirudins; Humans; Peptide Fragments; Pipecolic Acids; Platelet Aggregation Inhibitors; Recombinant Proteins; Sulfonamides; Thrombocytopenia; Thrombosis	2007
Heparin-induced thrombocytopenia without thrombosis: an evidence-based review of current literature. Critical care and resuscitation : journal of the Australasian Academy of Critical Care Medicine, 2006, Volume: 8, Issue:4 Topics: Anticoagulants; Arginine; Chondroitin Sulfates; Dermatan Sulfate; Evidence-Based Medicine; Heparin; Heparitin Sulfate; Hirudins; Humans; Pipecolic Acids; Recombinant Proteins; Sulfonamides; Thrombocytopenia	2006
Alternative anticoagulation management strategies for the patient with heparin-induced thrombocytopenia undergoing cardiac surgery. Journal of cardiothoracic and vascular anesthesia, 2007, Volume: 21, Issue:1 Topics: Ancrod; Anticoagulants; Arginine; Cardiac Surgical Procedures; Cardiopulmonary Bypass; Chondroitin Sulfates; Dermatan Sulfate; Heparin; Heparin, Low-Molecular-Weight; Heparitin Sulfate; Hirudins; Humans; Peptide Fragments; Pipecolic Acids; Platelet Aggregation Inhibitors; Recombinant Proteins; Sulfonamides; Thrombocytopenia	2007
Heparin-induced thrombocytopenia in intensive care patients. Critical care medicine, 2007, Volume: 35, Issue:4 Topics: Anticoagulants; Arginine; Chondroitin Sulfates; Dermatan Sulfate; Extracorporeal Circulation; Heparin; Heparitin Sulfate; Hirudins; Humans; Intensive Care Units; Pipecolic Acids; Recombinant Proteins; Sulfonamides; Thrombin; Thrombocytopenia; Thrombosis	2007
Heparin-induced thrombocytopenia: treatment options and special considerations. Pharmacotherapy, 2007, Volume: 27, Issue:4 Topics: Anticoagulants; Antithrombins; Arginine; Heparin; Hirudins; Humans; Peptide Fragments; Pipecolic Acids; Recombinant Proteins; Sulfonamides; Thrombocytopenia; Thrombosis	2007
Essentials of anticoagulation in hemodialysis. Hemodialysis international. International Symposium on Home Hemodialysis, 2007, Volume: 11, Issue:2 Topics: Anticoagulants; Arginine; Blood Coagulation; Chondroitin Sulfates; Dermatan Sulfate; Equipment Failure; Hemorrhage; Heparin; Heparitin Sulfate; Hirudins; Humans; Pipecolic Acids; Recombinant Proteins; Renal Dialysis; Renal Insufficiency, Chronic; Sulfonamides	2007
Heparin-induced thrombocytopenia and thrombosis. American journal of orthopedics (Belle Mead, N.J.), 2007, Volume: 36, Issue:5 Topics: Anticoagulants; Arginine; Chondroitin Sulfates; Dermatan Sulfate; Heparin; Heparitin Sulfate; Hirudins; Humans; Pipecolic Acids; Recombinant Proteins; Sulfonamides; Thrombocytopenia; Thrombosis	2007
Heparin induced thrombocytopenia: diagnosis and management update. Postgraduate medical journal, 2007, Volume: 83, Issue:983 Topics: Anticoagulants; Arginine; Cardiovascular Surgical Procedures; Chondroitin Sulfates; Dermatan Sulfate; Fibrinolytic Agents; Hemorrhage; Heparin; Heparitin Sulfate; Hirudins; Humans; Pipecolic Acids; Recombinant Proteins; Renal Dialysis; Sulfonamides; Thrombocytopenia; Warfarin	2007
Heparin induced thrombocytopenia: pathogenetic, clinical, diagnostic and therapeutic aspects. Cardiovascular & hematological disorders drug targets, 2007, Volume: 7, Issue:3 Topics: Animals; Anticoagulants; Arginine; Chondroitin Sulfates; Dermatan Sulfate; Heparin; Heparitin Sulfate; Hirudins; Humans; Peptide Fragments; Pipecolic Acids; Postoperative Complications; Recombinant Proteins; Sulfonamides; Thrombocytopenia	2007
Anticoagulation for acute coronary syndromes: from heparin to direct thrombin inhibitors. Reviews in cardiovascular medicine, 2007, Volume: 8 Suppl 3 Topics: Acute Disease; Angina Pectoris; Angina, Unstable; Angioplasty, Balloon, Coronary; Anticoagulants; Arginine; Fondaparinux; Hemorrhage; Heparin; Heparin, Low-Molecular-Weight; Hirudins; Humans; Models, Molecular; Molecular Structure; Myocardial Ischemia; Peptide Fragments; Pipecolic Acids; Platelet Activation; Polysaccharides; Recombinant Proteins; Sulfonamides; Syndrome; Thrombin; Thrombosis	2007
The laboratory diagnosis and clinical management of patients with heparin-induced thrombocytopenia: an update. Seminars in thrombosis and hemostasis, 2008, Volume: 34, Issue:1 Topics: Anticoagulants; Arginine; Chondroitin Sulfates; Dermatan Sulfate; Enzyme-Linked Immunosorbent Assay; Factor Xa Inhibitors; Heparin; Heparitin Sulfate; Hirudins; Peptide Fragments; Pipecolic Acids; Platelet Factor 4; Platelet Function Tests; Recombinant Proteins; Sulfonamides; Thrombin; Thrombocytopenia	2008
Heparins, low-molecular-weight heparins, and pentasaccharides: use in the older patient. Cardiology clinics, 2008, Volume: 26, Issue:2 Topics: Aged; Anticoagulants; Arginine; Enoxaparin; Fondaparinux; Heparin; Heparin, Low-Molecular-Weight; Hirudins; Humans; Pipecolic Acids; Polysaccharides; Recombinant Proteins; Sulfonamides	2008
New anticoagulant agents: direct thrombin inhibitors. Cardiology clinics, 2008, Volume: 26, Issue:2 Topics: Anticoagulants; Arginine; Atrial Fibrillation; Benzimidazoles; Dabigatran; Fibrinolytic Agents; Half-Life; Hirudins; Humans; Peptide Fragments; Pipecolic Acids; Pyridines; Recombinant Proteins; Stroke; Sulfonamides; Thrombin	2008
Heparin-induced thrombocytopenia: a review of current pharmacologic treatment. Connecticut medicine, 2008, Volume: 72, Issue:5 Topics: Anticoagulants; Antithrombin III; Arginine; Fondaparinux; Heparin; Hirudins; Humans; Pipecolic Acids; Polysaccharides; Recombinant Proteins; Sulfonamides; Thrombin; Thrombocytopenia	2008
Heparin-induced thrombocytopenia: what clinicians need to know. Thrombosis and haemostasis, 2009, Volume: 101, Issue:2 Topics: Anticoagulants; Arginine; Autoantibodies; Chondroitin Sulfates; Dermatan Sulfate; Drug Monitoring; Fondaparinux; Heparin; Heparitin Sulfate; Hirudins; Humans; Peptide Fragments; Pipecolic Acids; Platelet Count; Platelet Factor 4; Polysaccharides; Recombinant Proteins; Sulfonamides; Thrombocytopenia; Thrombosis; Warfarin	2009
Heparin-induced thrombocytopenia. A contemporary clinical approach to diagnosis and management. Chest, 2009, Volume: 135, Issue:6 Topics: Anticoagulants; Arginine; Chondroitin Sulfates; Dermatan Sulfate; Female; Heparin; Heparitin Sulfate; Hirudins; Humans; Male; Monitoring, Physiologic; Peptide Fragments; Pipecolic Acids; Platelet Aggregation Inhibitors; Platelet Count; Prognosis; Randomized Controlled Trials as Topic; Recombinant Proteins; Risk Factors; Safety Management; Severity of Illness Index; Sulfonamides; Survival Rate; Thrombocytopenia; Thrombosis; Time Factors	2009
Heparin-induced thrombocytopenia and cardiac surgery. Current opinion in anaesthesiology, 2010, Volume: 23, Issue:1 Topics: Anticoagulants; Arginine; Cardiovascular Surgical Procedures; Heparin; Hirudins; Humans; Peptide Fragments; Pipecolic Acids; Platelet Activation; Platelet Count; Platelet Factor 4; Recombinant Proteins; Sulfonamides; Thrombin; Thrombocytopenia	2010
Heparin-induced thrombocytopenia: when a low platelet count is a mandate for anticoagulation. Hematology. American Society of Hematology. Education Program, 2009 Topics: Anticoagulants; Arginine; Autoantibodies; Contraindications; Disseminated Intravascular Coagulation; Fondaparinux; Heparin; Hirudins; Humans; Pipecolic Acids; Platelet Count; Platelet Factor 4; Polysaccharides; Recombinant Proteins; Sulfonamides; Thrombocytopenia; Thrombophilia; Time Factors; Venous Thromboembolism; Vitamin K; Warfarin	2009
Thrombosis prophylaxis in critically ill patients. Wiener medizinische Wochenschrift (1946), 2011, Volume: 161, Issue:3-4 Topics: Anticoagulants; Arginine; Biological Availability; Chromosome Breakage; Chromosome Disorders; Critical Care; Dose-Response Relationship, Drug; Drug Resistance; Heparin; Heparin, Low-Molecular-Weight; Hirudins; Humans; Infusions, Intravenous; Injections, Subcutaneous; Pipecolic Acids; Recombinant Proteins; Risk Factors; Sepsis; Severity of Illness Index; Shock, Septic; Sulfonamides; Thrombin; Thrombocytopenia; Venous Thrombosis	2011
Pharmacokinetic evaluation of argatroban for the treatment of acute coronary syndrome. Expert opinion on drug metabolism & toxicology, 2012, Volume: 8, Issue:11 Topics: Acute Coronary Syndrome; Animals; Antithrombins; Arginine; Disease Models, Animal; Drug Evaluation; Heparin; Hirudins; Humans; Peptide Fragments; Percutaneous Coronary Intervention; Pipecolic Acids; Randomized Controlled Trials as Topic; Recombinant Proteins; Sulfonamides; Thrombocytopenia; Thrombosis	2012
Translational success stories: development of direct thrombin inhibitors. Circulation research, 2012, Sep-14, Volume: 111, Issue:7 Topics: Anticoagulants; Antithrombins; Arginine; Hirudin Therapy; Hirudins; Humans; Peptide Fragments; Pipecolic Acids; Recombinant Proteins; Sulfonamides; Thrombosis; Translational Research, Biomedical	2012
Comparisons of argatroban to lepirudin and bivalirudin in the treatment of heparin-induced thrombocytopenia: a systematic review and meta-analysis. International journal of hematology, 2017, Volume: 106, Issue:4 Topics: Arginine; Female; Heparin; Hirudins; Humans; Male; Pipecolic Acids; Recombinant Proteins; Sulfonamides; Thrombocytopenia	2017

Trials

3 trial(s) available for arginine and refludan

Article	Year
Evaluation of a standardized protocol using lepirudin or argatroban for heparin-induced thrombocytopenia. Cardiovascular & hematological agents in medicinal chemistry, 2011, Volume: 9, Issue:4 Topics: Aged; Anticoagulants; Antithrombins; Arginine; Female; Heparin; Hirudins; Humans; Male; Middle Aged; Partial Thromboplastin Time; Pipecolic Acids; Platelet Aggregation Inhibitors; Recombinant Proteins; Sulfonamides; Thrombocytopenia; Treatment Outcome	2011
Argatroban versus Lepirudin in critically ill patients (ALicia): a randomized controlled trial. Critical care (London, England), 2014, Oct-25, Volume: 18, Issue:5 Topics: Aged; Aged, 80 and over; Anticoagulants; Antithrombins; Arginine; Critical Illness; Female; Hemorrhage; Heparin; Hirudins; Humans; Male; Middle Aged; Partial Thromboplastin Time; Pipecolic Acids; Recombinant Proteins; Renal Insufficiency; Renal Replacement Therapy; Sulfonamides; Surgical Procedures, Operative; Thrombocytopenia	2014
Monitoring of argatroban and lepirudin anticoagulation in critically ill patients by conventional laboratory parameters and rotational thromboelastometry - a prospectively controlled randomized double-blind clinical trial. BMC anesthesiology, 2018, 02-09, Volume: 18, Issue:1 Topics: Aged; Anticoagulants; Arginine; Blood Coagulation; Blood Coagulation Tests; Critical Illness; Double-Blind Method; Drug Monitoring; Female; Hirudins; Humans; Male; Middle Aged; Pipecolic Acids; Recombinant Proteins; Sulfonamides; Thrombelastography	2018

Other Studies

50 other study(ies) available for arginine and refludan

Article	Year
Inhibition of thrombin generation in plasma by inhibitors of factor Xa. Thrombosis and haemostasis, 1997, Volume: 78, Issue:4 Topics: Animals; Anticoagulants; Arginine; Arthropod Proteins; Cattle; Dipeptides; Factor Xa; Factor Xa Inhibitors; Fibrinolytic Agents; Hirudins; Humans; Intercellular Signaling Peptides and Proteins; Kinetics; Molecular Structure; Naphthalenes; Partial Thromboplastin Time; Peptides; Pipecolic Acids; Piperidines; Propionates; Rabbits; Recombinant Proteins; Serine Proteinase Inhibitors; Sulfonamides; Sulfones; Thrombin; Thromboplastin	1997
Direct thrombin inhibitors: are they the future of anticoagulation? South Dakota journal of medicine, 2001, Volume: 54, Issue:6 Topics: Anticoagulants; Arginine; Hirudins; Humans; Peptide Fragments; Pipecolic Acids; Recombinant Proteins; Sulfonamides; Thrombin	2001
Comment: treatment of heparin-induced thrombocytopenia. The Annals of pharmacotherapy, 2002, Volume: 36, Issue:9 Topics: Anticoagulants; Arginine; Heparin; Hirudins; Humans; International Normalized Ratio; Pipecolic Acids; Recombinant Proteins; Sulfonamides; Thrombin; Thrombocytopenia; Warfarin	2002
Venous limb gangrene during overlapping therapy with warfarin and a direct thrombin inhibitor for immune heparin-induced thrombocytopenia. American journal of hematology, 2002, Volume: 71, Issue:1 Topics: Aged; Aged, 80 and over; Amputation, Surgical; Anticoagulants; Arginine; Autoimmune Diseases; Catheterization, Central Venous; Contraindications; Drug Administration Schedule; Drug Therapy, Combination; Female; Gangrene; Heparin; Hirudin Therapy; Hirudins; Humans; International Normalized Ratio; Leg; Male; Middle Aged; Necrosis; Pipecolic Acids; Protein C Deficiency; Recombinant Proteins; Sulfonamides; Surgical Wound Infection; Thrombin; Thrombocytopenia; Thrombophlebitis; Warfarin	2002
Monitoring of anticoagulant effects of direct thrombin inhibitors. Seminars in thrombosis and hemostasis, 2002, Volume: 28, Issue:4 Topics: Anticoagulants; Arginine; Azetidines; Benzylamines; Blood Coagulation Tests; Drug Monitoring; Glycine; Heparin; Hirudins; Humans; Pipecolic Acids; Recombinant Proteins; Sensitivity and Specificity; Sulfonamides; Thrombin	2002
Influence of lepirudin, argatroban, and melagatran on prothrombin time and additional effect of oral anticoagulation. Clinical chemistry, 2002, Volume: 48, Issue:10 Topics: Administration, Oral; Anticoagulants; Arginine; Azetidines; Benzylamines; Drug Synergism; Glycine; Hirudins; Humans; Phenprocoumon; Pipecolic Acids; Prothrombin Time; Recombinant Proteins; Sulfonamides	2002
Preventing complications in heparin-induced thrombocytopenia. Alternative anticoagulants are improving patient outcomes. Postgraduate medicine, 2002, Volume: 112, Issue:3 Topics: Anticoagulants; Arginine; Chondroitin Sulfates; Dermatan Sulfate; Drug Combinations; Heparin; Heparinoids; Heparitin Sulfate; Hirudin Therapy; Hirudins; Humans; Pipecolic Acids; Recombinant Proteins; Sulfonamides; Thrombocytopenia	2002
Direct antithrombin agents ameliorate disseminated intravascular coagulation in suspected heparin-induced thrombocytopenia thrombosis syndrome. Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis, 2002, Volume: 8, Issue:3 Topics: Adult; Aged; Arginine; Disseminated Intravascular Coagulation; Female; Fibrinolytic Agents; Heparin; Hirudins; Humans; Male; Middle Aged; Pipecolic Acids; Recombinant Proteins; Sulfonamides; Thrombocytopenia	2002
Treatment options for heparin-induced thrombocytopenia. American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 2003, Oct-15, Volume: 60 Suppl 5 Topics: Antithrombins; Arginine; Heparin; Hirudins; Humans; Pipecolic Acids; Recombinant Proteins; Sulfonamides; Thrombocytopenia; Thrombosis; United States	2003
Effect of direct thrombin inhibitors, bivalirudin, lepirudin, and argatroban, on prothrombin time and INR values. American journal of clinical pathology, 2004, Volume: 121, Issue:4 Topics: Antithrombins; Arginine; Dose-Response Relationship, Drug; Hirudins; Humans; In Vitro Techniques; International Normalized Ratio; Peptide Fragments; Pipecolic Acids; Prothrombin Time; Recombinant Proteins; Sulfonamides	2004
Comparing direct thrombin inhibitors using aPTT, ecarin clotting times, and thrombin inhibitor management testing. The Annals of pharmacotherapy, 2004, Volume: 38, Issue:9 Topics: Arginine; Blood Coagulation; Dose-Response Relationship, Drug; Endopeptidases; Fibrinolytic Agents; Hirudins; Humans; In Vitro Techniques; Partial Thromboplastin Time; Peptide Fragments; Pipecolic Acids; Recombinant Proteins; Sulfonamides; Thrombin	2004
Effects of pentasaccharide (fondaparinux) and direct thrombin inhibitors on coagulation testing. Archives of pathology & laboratory medicine, 2004, Volume: 128, Issue:10 Topics: Antithrombins; Arginine; Blood Coagulation Tests; Fondaparinux; Hirudins; Humans; Peptide Fragments; Pipecolic Acids; Polysaccharides; Recombinant Proteins; Sulfonamides	2004
Treatment of patients with a history of heparin-induced thrombocytopenia and anti-lepirudin antibodies with argatroban. Journal of thrombosis and thrombolysis, 2005, Volume: 19, Issue:1 Topics: Aged; Antibodies; Anticoagulants; Arginine; Enzyme-Linked Immunosorbent Assay; Female; Heparin; Hirudin Therapy; Hirudins; Humans; Immunoglobulin G; Male; Middle Aged; Pipecolic Acids; Platelet Aggregation Inhibitors; Recombinant Proteins; Sulfonamides; Thrombocytopenia	2005
Collaborative study on monitoring methods to determine direct thrombin inhibitors lepirudin and argatroban. Journal of thrombosis and haemostasis : JTH, 2005, Volume: 3, Issue:9 Topics: Arginine; Blood Coagulation Tests; Cooperative Behavior; Drug Monitoring; Enzyme-Linked Immunosorbent Assay; Fibrinolytic Agents; Hirudins; Humans; Methods; Pipecolic Acids; Recombinant Proteins; Reproducibility of Results; Sulfonamides; Thrombin	2005
The paradox of heparin-induced thrombocytopenia: the initial management. Orthopedics, 2005, Volume: 28, Issue:6 Topics: Anticoagulants; Arginine; Heparin; Hirudins; Humans; Pipecolic Acids; Platelet Aggregation Inhibitors; Recombinant Proteins; Sulfonamides; Thrombocytopenia	2005
Argatroban and lepirudin requirements in a 6-year-old patient with heparin-induced thrombocytopenia. Pharmacotherapy, 2005, Volume: 25, Issue:10 Topics: Anticoagulants; Arginine; Child; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Female; Heparin; Hirudins; Humans; Partial Thromboplastin Time; Pipecolic Acids; Recombinant Proteins; Sulfonamides; Thrombocytopenia	2005
Argatroban and lepirudin: clinical trials to clinical practice. Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis, 2005, Volume: 11, Issue:4 Topics: Anticoagulants; Arginine; Clinical Trials as Topic; Hirudins; Humans; Pipecolic Acids; Recombinant Proteins; Sulfonamides	2005
A comparison of lepirudin and argatroban outcomes. Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis, 2005, Volume: 11, Issue:4 Topics: Aged; Anticoagulants; Arginine; Female; Hemorrhage; Hirudins; Humans; Male; Pipecolic Acids; Recombinant Proteins; Sulfonamides; Thrombin; Treatment Outcome	2005
Evaluation of diagnostic tests and argatroban or lepirudin therapy in patients with suspected heparin-induced thrombocytopenia. Pharmacotherapy, 2005, Volume: 25, Issue:12 Topics: Anticoagulants; Arginine; Cohort Studies; Female; Heparin; Hirudins; Humans; Male; Middle Aged; Partial Thromboplastin Time; Pipecolic Acids; Platelet Activation; Platelet Aggregation; Recombinant Proteins; Retrospective Studies; Sulfonamides; Thrombocytopenia	2005
Differences in the clinically effective molar concentrations of four direct thrombin inhibitors explain their variable prothrombin time prolongation. Thrombosis and haemostasis, 2005, Volume: 94, Issue:5 Topics: Animals; Anticoagulants; Arginine; Azetidines; Benzylamines; Blood Coagulation; Cattle; Dose-Response Relationship, Drug; Factor Xa; Factor Xa Inhibitors; Glycine; Hirudins; Humans; In Vitro Techniques; Partial Thromboplastin Time; Peptide Fragments; Pipecolic Acids; Prothrombin Time; Recombinant Proteins; Species Specificity; Sulfonamides; Thrombin; Thrombin Time; Thromboplastin	2005
Heparin-induced thrombocytopenia and cardiovascular patients: recognition and treatment. Progress in cardiovascular nursing, 2006,Winter, Volume: 21, Issue:1 Topics: Anticoagulants; Arginine; Heparin; Hirudins; Humans; Peptide Fragments; Pipecolic Acids; Platelet Factor 4; Recombinant Proteins; Sulfonamides; Thrombocytopenia	2006
Evaluation of treatment with direct thrombin inhibitors in patients with heparin-induced thrombocytopenia. Pharmacotherapy, 2006, Volume: 26, Issue:4 Topics: Adult; Aged; Aged, 80 and over; Anticoagulants; Arginine; Female; Heparin; Hirudins; Humans; Male; Middle Aged; Partial Thromboplastin Time; Peptide Fragments; Pipecolic Acids; Recombinant Proteins; Retrospective Studies; Sulfonamides; Thrombin; Thrombocytopenia; Time Factors; Treatment Outcome	2006
Argatroban, bivalirudin, and lepirudin do not decrease clot propagation and strength as effectively as heparin-activated antithrombin in vitro. The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation, 2006, Volume: 25, Issue:6 Topics: Anticoagulants; Antithrombins; Arginine; Cardiopulmonary Bypass; Child; Dose-Response Relationship, Drug; Fatal Outcome; Female; Fibrinolytic Agents; Heart Transplantation; Heparin; Hirudins; Humans; Peptide Fragments; Pipecolic Acids; Platelet Aggregation Inhibitors; Recombinant Proteins; Sulfonamides; Thrombelastography; Thrombocytopenia; Treatment Failure; Whole Blood Coagulation Time	2006
[Two surgical case reports showing atypical heparin-induced thrombocytopenia]. Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen, 2007, Volume: 78, Issue:2 Topics: Adult; Anticoagulants; Arginine; Chondroitin Sulfates; Dermatan Sulfate; Drug Eruptions; Female; Heparin; Heparin, Low-Molecular-Weight; Heparitin Sulfate; Hirudins; Humans; Male; Pipecolic Acids; Platelet Count; Platelet Factor 4; Postoperative Complications; Recombinant Proteins; Sulfonamides; Thrombocytopenia; Thrombosis; Time Factors	2007
Impact of smart infusion technology on administration of anticoagulants (unfractionated Heparin, Argatroban, Lepirudin, and Bivalirudin). The American journal of cardiology, 2007, Apr-01, Volume: 99, Issue:7 Topics: Anticoagulants; Arginine; Boston; Drug Overdose; Drug Therapy, Computer-Assisted; Heparin; Hirudins; Humans; Infusion Pumps; Infusions, Intravenous; Medication Errors; Medication Systems, Hospital; Peptide Fragments; Pipecolic Acids; Recombinant Proteins; Research Design; Sulfonamides	2007
Seizures, headache and thrombocytopenia: diagnosis and treatment do not always come in a standard sequence. Internal and emergency medicine, 2007, Volume: 2, Issue:3 Topics: Arginine; Female; Headache; Heparin, Low-Molecular-Weight; Hirudins; Humans; Middle Aged; Pipecolic Acids; Recombinant Proteins; Seizures; Sulfonamides; Thrombocytopenia	2007
Fondaparinux versus direct thrombin inhibitor therapy for the management of heparin-induced thrombocytopenia (HIT)--bridging the River Coumarin. Thrombosis and haemostasis, 2008, Volume: 99, Issue:1 Topics: Acute Disease; Anticoagulants; Arginine; Blood Coagulation; Factor Xa Inhibitors; Fondaparinux; Hemorrhage; Heparin; Hirudins; Humans; International Normalized Ratio; Pipecolic Acids; Platelet Count; Polysaccharides; Recombinant Proteins; Research Design; Sulfonamides; Thrombin; Thrombocytopenia; Treatment Outcome; Venous Thrombosis; Warfarin	2008
Standardizing the management of heparin-induced thrombocytopenia. American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 2008, Feb-15, Volume: 65, Issue:4 Topics: Anticoagulants; Arginine; Clinical Protocols; Evidence-Based Medicine; Fondaparinux; Heparin; Hirudins; Humans; Pipecolic Acids; Platelet Count; Platelet Function Tests; Polysaccharides; Recombinant Proteins; Retrospective Studies; Sulfonamides; Thrombocytopenia	2008
[Heparin induced thrombocytopenia and anticoagulation in renal replacemant therapy]. Anasthesiologie, Intensivmedizin, Notfallmedizin, Schmerztherapie : AINS, 2008, Volume: 43, Issue:4 Topics: Acute Kidney Injury; Anticoagulants; Arginine; Blood Coagulation Tests; Chondroitin Sulfates; Citrates; Critical Care; Dermatan Sulfate; Diagnostic Errors; Dose-Response Relationship, Drug; Epoprostenol; Fondaparinux; Hemofiltration; Heparin; Heparin, Low-Molecular-Weight; Heparitin Sulfate; Hirudins; Humans; Iloprost; Pipecolic Acids; Polysaccharides; Recombinant Proteins; Sodium Citrate; Sulfonamides; Thrombocytopenia; Thrombosis	2008
Management of anticoagulation in patients with subacute heparin-induced thrombocytopenia scheduled for heart transplantation. Blood, 2008, Nov-15, Volume: 112, Issue:10 Topics: Adult; Anticoagulants; Arginine; Autoantibodies; Heart Failure; Heart Transplantation; Heparin; Hirudins; Humans; Male; Middle Aged; Pipecolic Acids; Platelet Factor 4; Recombinant Proteins; Sulfonamides; Thrombocytopenia	2008
A comparison of direct thrombin inhibitors in the treatment of Heparin-Induced Thrombocytopenia: a single institution experience. Journal of thrombosis and thrombolysis, 2009, Volume: 28, Issue:2 Topics: Aged; Anticoagulants; Arginine; Female; Heparin; Hirudins; Humans; Male; Middle Aged; Pipecolic Acids; Recombinant Proteins; Retrospective Studies; Sulfonamides; Thrombocytopenia	2009
The effect of ex vivo anticoagulants on whole blood platelet aggregation. Platelets, 2009, Volume: 20, Issue:1 Topics: Adenosine Diphosphate; Anticoagulants; Arachidonic Acid; Arginine; Azetidines; Benzylamines; Blood Platelets; Citric Acid; Collagen; Female; Heparin; Hirudins; Humans; Male; Peptide Fragments; Pipecolic Acids; Platelet Aggregation; Platelet Function Tests; Recombinant Proteins; Ristocetin; Sulfonamides; Time Factors	2009
[Heparin-induced thrombocytopenia]. Ugeskrift for laeger, 2009, Feb-16, Volume: 171, Issue:8 Topics: Anticoagulants; Arginine; Chondroitin Sulfates; Dermatan Sulfate; Fibrinolytic Agents; Heparin; Heparitin Sulfate; Hirudins; Humans; Pipecolic Acids; Recombinant Proteins; Risk Factors; Sulfonamides; Thrombocytopenia	2009
The direct thrombin inhibitors (argatroban, bivalirudin and lepirudin) and the indirect Xa-inhibitor (danaparoid) increase fibrin network porosity and thus facilitate fibrinolysis. Thrombosis and haemostasis, 2010, Volume: 103, Issue:5 Topics: Antithrombins; Arginine; Chondroitin Sulfates; Chromatography, Gel; Dermatan Sulfate; Factor VIII; Factor Xa Inhibitors; Fibrin; Fibrinolysis; Heparinoids; Heparitin Sulfate; Hirudins; Humans; In Vitro Techniques; Microscopy, Confocal; Peptide Fragments; Pipecolic Acids; Plasma; Porosity; Protein Multimerization; Recombinant Proteins; Sulfonamides; Thrombosis; Tissue Plasminogen Activator	2010
Monitoring of the anticoagulants argatroban and lepirudin: a comparison of laboratory methods. Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis, 2011, Volume: 17, Issue:5 Topics: Antithrombins; Arginine; Calibration; Female; Hirudins; Humans; Male; Partial Thromboplastin Time; Pipecolic Acids; Prothrombin Time; Recombinant Proteins; Sulfonamides; Thrombin Time	2011
Thrombolytic therapy and thrombectomy in phlegmasia cerulea dolens. The journal of the Royal College of Physicians of Edinburgh, 2010, Volume: 40, Issue:1 Topics: Anticoagulants; Antithrombins; Arginine; Fibrinolytic Agents; Heparin; Hirudins; Humans; Pipecolic Acids; Platelet Aggregation Inhibitors; Recombinant Proteins; Sulfonamides; Thrombectomy; Thrombocytopenia; Time Factors; Venous Thrombosis	2010
Practical viewpoints on the diagnosis and management of heparin-induced thrombocytopenia. Seminars in thrombosis and hemostasis, 2011, Volume: 37, Issue:3 Topics: Aged; Anticoagulants; Arginine; Cardiac Catheterization; Cardiac Surgical Procedures; Chondroitin Sulfates; Dermatan Sulfate; Female; Heparin; Heparin, Low-Molecular-Weight; Heparitin Sulfate; Hirudins; Humans; Male; Peptide Fragments; Pipecolic Acids; Recombinant Proteins; Sulfonamides; Thrombocytopenia; Vascular Surgical Procedures; Vitamin K; Young Adult	2011
Development and implementation of a comprehensive heparin-induced thrombocytopenia recognition and management protocol. American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 2012, Feb-01, Volume: 69, Issue:3 Topics: Academic Medical Centers; Anticoagulants; Antithrombins; Arginine; Heparin; Hirudins; Humans; Joint Commission on Accreditation of Healthcare Organizations; Patient Education as Topic; Pharmacists; Pipecolic Acids; Practice Guidelines as Topic; Quality Assurance, Health Care; Recombinant Proteins; Sulfonamides; Thrombin; Thrombocytopenia; United States	2012
In vivo fluorescence imaging of atherosclerotic plaques with activatable cell-penetrating peptides targeting thrombin activity. Integrative biology : quantitative biosciences from nano to macro, 2012, Volume: 4, Issue:6 Topics: Amino Acid Sequence; Animals; Antithrombins; Aorta; Arginine; Cell-Penetrating Peptides; Fluorescent Dyes; Hirudins; Histocytochemistry; Humans; Mice; Mice, Inbred C57BL; Mice, Knockout; Mice, Transgenic; Microscopy, Fluorescence; Pipecolic Acids; Plaque, Atherosclerotic; Receptor, PAR-1; Recombinant Proteins; Sulfonamides; Thrombin	2012
The therapeutic management of bleeding and thrombotic disorders complicating CNS malignancies. Current treatment options in oncology, 2012, Volume: 13, Issue:4 Topics: Antibodies, Monoclonal, Humanized; Anticoagulants; Arginine; Bevacizumab; Central Nervous System Neoplasms; Fondaparinux; Glioblastoma; Glioma; Hemorrhage; Heparin, Low-Molecular-Weight; Hirudins; Humans; Pipecolic Acids; Polysaccharides; Postoperative Complications; Pulmonary Embolism; Recombinant Proteins; Sulfonamides; Thrombocytopenia; Vena Cava Filters; Venous Thromboembolism; Venous Thrombosis; Warfarin	2012
Direct thrombin inhibitors for management of heparin-induced thrombocytopenia in patients receiving renal replacement therapy: comparison of clinical outcomes. American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 2012, Sep-15, Volume: 69, Issue:18 Topics: Adult; Aged; Anticoagulants; Antithrombins; Arginine; Female; Heparin; Hirudins; Humans; International Normalized Ratio; Male; Middle Aged; Peptide Fragments; Pipecolic Acids; Platelet Count; Recombinant Proteins; Renal Replacement Therapy; Retrospective Studies; Serum Albumin; Sulfonamides; Thrombocytopenia	2012
Measuring direct thrombin inhibitors with routine and dedicated coagulation assays: which assay is helpful? American journal of clinical pathology, 2012, Volume: 138, Issue:4 Topics: Antithrombins; Arginine; Blood Coagulation; Chromogenic Compounds; Diagnostic Tests, Routine; Endopeptidases; Fibrinolytic Agents; Hirudins; Humans; Partial Thromboplastin Time; Peptide Fragments; Pipecolic Acids; Prothrombin Time; Recombinant Proteins; Sulfonamides; Thrombin; Thrombin Time	2012
Monitoring the direct thrombin inhibitors. Clinical laboratory science : journal of the American Society for Medical Technology, 2013,Winter, Volume: 26, Issue:1 Topics: Antithrombins; Arginine; Benzimidazoles; beta-Alanine; Dabigatran; Drug Monitoring; Hirudins; Humans; Peptide Fragments; Pipecolic Acids; Recombinant Proteins; Sulfonamides	2013
Direct thrombin inhibitors and factor xa inhibitors can influence the diluted prothrombin time used as the initial screen for lupus anticoagulant. Archives of pathology & laboratory medicine, 2013, Volume: 137, Issue:7 Topics: Anticoagulants; Antithrombins; Arginine; Chondroitin Sulfates; Dermatan Sulfate; Enoxaparin; Factor Xa Inhibitors; False Positive Reactions; Fondaparinux; Heparitin Sulfate; Hirudins; Humans; Lupus Coagulation Inhibitor; Mass Screening; Pipecolic Acids; Polysaccharides; Prothrombin Time; Recombinant Proteins; Sulfonamides; Thrombin	2013
Trends in parenteral direct thrombin inhibitor use in pediatric patients: analysis of a large administrative database. Archives of pathology & laboratory medicine, 2014, Volume: 138, Issue:9 Topics: Adolescent; Age Factors; Antithrombins; Arginine; Child; Child, Preschool; Databases, Factual; Female; Health Information Systems; Hemorrhage; Hirudins; Humans; Incidence; Infant; Infant, Newborn; Infusions, Parenteral; Male; Peptide Fragments; Pipecolic Acids; Recombinant Proteins; Retrospective Studies; Sulfonamides; Thrombocytopenia; Young Adult	2014
Comparison of bivalirudin to lepirudin and argatroban in patients with heparin-induced thrombocytopenia. American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 2015, Sep-01, Volume: 72, Issue:17 Suppl 2 Topics: Aged; Anticoagulants; Antithrombins; Arginine; Dose-Response Relationship, Drug; Female; Hemorrhage; Heparin; Hirudins; Humans; International Normalized Ratio; Male; Middle Aged; Partial Thromboplastin Time; Peptide Fragments; Pipecolic Acids; Recombinant Proteins; Retrospective Studies; Sulfonamides; Thrombocytopenia	2015
Overtreatment of Heparin-Induced Thrombocytopenia in the Surgical ICU. Critical care medicine, 2017, Volume: 45, Issue:1 Topics: Academic Medical Centers; Aged; Antibodies; Anticoagulants; Antithrombins; Arginine; Enzyme-Linked Immunosorbent Assay; Female; Fondaparinux; Heparin; Hirudins; Humans; Intensive Care Units; Male; Medical Overuse; Middle Aged; Pipecolic Acids; Platelet Factor 4; Polysaccharides; Prospective Studies; Recombinant Proteins; Serotonin; Sulfonamides; Thrombocytopenia	2017
Monitoring of Argatroban and Lepirudin: What is the Input of Laboratory Values in "Real Life"? Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis, 2018, Volume: 24, Issue:2 Topics: Antithrombins; Arginine; Blood Coagulation Tests; Drug Monitoring; Heparin; Hirudins; Humans; Partial Thromboplastin Time; Pipecolic Acids; Prothrombin Time; Recombinant Proteins; Sulfonamides; Thrombin Time; Thrombocytopenia	2018
Use of Fondaparinux Off-Label or Approved Anticoagulants for Management of Heparin-Induced Thrombocytopenia. Journal of the American College of Cardiology, 2017, Nov-28, Volume: 70, Issue:21 Topics: Anticoagulants; Arginine; Chondroitin Sulfates; Dermatan Sulfate; Factor Xa Inhibitors; Female; Fondaparinux; Hemorrhage; Heparin; Heparitin Sulfate; Hirudins; Hospital Mortality; Hospitalization; Humans; Male; Necrosis; Off-Label Use; Partial Thromboplastin Time; Patient Safety; Pipecolic Acids; Polysaccharides; Recombinant Proteins; Registries; Retrospective Studies; Sulfonamides; Thrombocytopenia; Thromboembolism; Treatment Outcome	2017
Heparin-Induced Thrombocytopenia during Obstetric Hospital Admissions. American journal of perinatology, 2018, Volume: 35, Issue:9 Topics: Adolescent; Adult; Arginine; Databases, Factual; Delivery, Obstetric; Female; Fondaparinux; Heparin; Heparin, Low-Molecular-Weight; Hirudins; Hospitalization; Humans; Middle Aged; Peptide Fragments; Pipecolic Acids; Postpartum Period; Pregnancy; Recombinant Proteins; Risk Assessment; Sulfonamides; Thrombocytopenia; United States; Young Adult	2018